U.S. External Defibrillators Market To Reach $2.33 Billion By 2030

U.S. External Defibrillators Market Growth & Trends

The U.S. external defibrillators market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of cardiovascular conditions is a major factor contributing to market growth. As per the Centers for Disease Control and Prevention (CDC), every year in the U.S., around 805,000 people have a heart attack. Technological advancements have led to the development of innovative external defibrillators. In addition, the growing healthcare expenditure in the U.S., coupled with investments in emergency medical services and healthcare infrastructure, has supported the product adoption in hospitals, clinics, ambulances, and other healthcare facilities.

This increased investment in healthcare facilities has boosted the demand for advanced defibrillation technologies. Public awareness campaigns about sudden cardiac arrest & the importance of early defibrillation, along with training programs on using automated external defibrillators (AEDs) effectively, have played a crucial role in driving market growth. Increased awareness has led to a higher demand for defibrillators in public settings and private organizations. Key companies undertake various strategies, such as new product launches, M&As, and partnerships, to gain higher market shares. For instance, in March 2023, Safe Life acquired Coro Medical and AED.us. This acquisition helped expand Safe Life’s life-saving equipment and services across the U.S.

 Request a free sample copy or view report summary: U.S. External Defibrillators Market Report

U.S. External Defibrillators Market Report Highlights

• The AED product segment dominated the market in 2023 and around for a share of 40% of the overall revenue. The segment is expected to grow at the fastest CAGR from 2024 to 2030

• This can be attributed to the technological advancements in defibrillator devices, increasing prevalence of cardiovascular diseases (CVDs), and growing awareness about the importance of immediate cardiac care

• The hospital end-use segment accounted for the largest revenue share of over 25% in 2023 owing to increased rates of hospital admissions due to heart conditions and increasing defibrillator installations

• The public access end-use segment is anticipated to witness the fastest CAGR from 2024 to 2030 due to the rising awareness of the importance of early defibrillation and training programs

U.S. External Defibrillators Market Segmentation

Grand View Research has segmented the U.S. external defibrillation market on the basis of product and end-use:

U.S. External Defibrillators Product Outlook (Revenue, USD Million, 2018 - 2030)

• Manual

• Automated

  • Semi-automated

  • Fully-automated

• Wearable Cardioverter Defibrillators

U.S. External Defibrillators End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

• Prehospital

• Public Access Market

• Alternate Care Market

• Home Healthcare

List of Key Players in the U.S. External Defibrillators Market

• Koninklijke Philips N.V.

• ZOLL Medical Corporation

• Stryker

• Nihon Kohden Corporation

• Shenzhen Mindray Bio-Medical Electronics

• Schiller Americas, Inc.

• Medtronic

• Amiitalia

• MEDIANA Co., Ltd.